Analisis Pengaruh Ukuran Perusahaan, Leverage, dan Profitabilitas Terhadap Opini Going Concern
Jurnal Semesta Ilmu Manajemen dan Ekonomi · 10.06.2026 · 2 (4) · 1512-1524
DOI: 10.71417/j-sime.v2i4.1983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Semesta Ilmu Manajemen dan Ekonomi, online erschienen am 10.06.2026. Verfasst von Rasendria Arya Guna und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
The objective of this study is to examine the influence of firm size, leverage, and profitability on going concern opinion on energy sector mining companies listed on the Indonesia Stock Exchange (IDX) during the period of 2021 to 2023. Sample selection was determined using a purposive sampling method, resulting in a total sample of 168. The data analysis technique employed is logistic regression to test each hypothesis in this research. The results of this study indicate that a higher level of leverage and a lower level of profitability in a company can increase the likelihood of a going concern opinion. However, firm size does not affect the going concern opinion. The results of this study can be a factor of consideration for investors, auditors, and company management
Zitieren
APA
Guna, R. A., & Zaky, A. (2026). Analisis Pengaruh Ukuran Perusahaan, Leverage, dan Profitabilitas Terhadap Opini Going Concern. Jurnal Semesta Ilmu Manajemen dan Ekonomi, 2(4), 1512-1524. https://doi.org/10.71417/j-sime.v2i4.1983
Vancouver
Guna RA, Zaky A. Analisis Pengaruh Ukuran Perusahaan, Leverage, dan Profitabilitas Terhadap Opini Going Concern. Jurnal Semesta Ilmu Manajemen dan Ekonomi. 2026;2(4):1512-1524. doi:10.71417/j-sime.v2i4.1983
BibTeX
@article{Guna2026,
author = {Guna, Rasendria Arya and Zaky, Achmad},
title = {Analisis Pengaruh Ukuran Perusahaan, Leverage, dan Profitabilitas Terhadap Opini Going Concern},
journal = {Jurnal Semesta Ilmu Manajemen dan Ekonomi},
year = {2026},
volume = {2},
number = {4},
pages = {1512--1524},
doi = {10.71417/j-sime.v2i4.1983}
}
EUVIMED